DoubleRainbow, which is based in Cambridge, MA, released the new ingredient under the aegis of a subsidiary known as Landkind. Grant Smith, vice president of corporate strategy and chief brand officer for Landkind, sat down with NutraIngredient-USA to give a rundown of the production process for the new offering and what he sees as its potential.
Getting to the precise benefits of an adaptogen
Smith said the company focused first on Rhodiola because of the vast potential of the botanical. What was needed, he said, was a more focused concept of both of the botanical’s message and its health effects.
Commonly referred to as a adaptogen, rhodiola has historically been mentioned in connection with stress management and mood support. An issue with the adaptogenic positioning early on was that marketers seemed to be promoting this and other adaptogenic ingredients for a whole host of issues. Good for what ails ya, in other words. It was a way of formulating that message that was rife with abuse and misunderstanding and the potential for both overpromising and underdelivering.
With LK-01, however, Smith said Landkind can hone that message as it pertains to the effects of a 99.5% pure biosynthetic ingredient. The salidroside molecule that is the target of the development effort is present at only about 1% by weight in the parent plant, Smith said.
“At its core Rhodiola is an adaptogen. But it’s the salidroside that is helping at the cellular level, where it is improving metabolic function and improving ATP production,” he said.
Bioengineered salidroside ingredient launches as part of extensive development effort - NutraIngredients-usa.com
Read More
No comments:
Post a Comment